
Sign up to save your podcasts
Or


In this episode, Marc Bloomenstein, OD, FAAO, talks with Mitch Ibach, OD, FAAO, who practices at Vance Thompson Vision, in Sioux Falls, South Dakota, an OD-MD tertiary referral center. The pair opened the conversation with what’s new and exciting in patient care, including a newly-approved presbyopia combination drop, carbachol and brimonidine tartrate (Yuvezzi, Tenpoint Pharmaceuticals). Dr. Ibach then shared a few developments coming out of Vance Thompson, including an ocular IOP-adjusting pump for significant glaucomatous disease and the benefits of cultured endothelial cells for Fuchs dystrophy.
By Modern Optometry4.4
55 ratings
In this episode, Marc Bloomenstein, OD, FAAO, talks with Mitch Ibach, OD, FAAO, who practices at Vance Thompson Vision, in Sioux Falls, South Dakota, an OD-MD tertiary referral center. The pair opened the conversation with what’s new and exciting in patient care, including a newly-approved presbyopia combination drop, carbachol and brimonidine tartrate (Yuvezzi, Tenpoint Pharmaceuticals). Dr. Ibach then shared a few developments coming out of Vance Thompson, including an ocular IOP-adjusting pump for significant glaucomatous disease and the benefits of cultured endothelial cells for Fuchs dystrophy.

3,242 Listeners

43 Listeners

75 Listeners

113,121 Listeners

8,043 Listeners

102 Listeners

80 Listeners

15 Listeners

21 Listeners

16,982 Listeners

19 Listeners

19 Listeners

10 Listeners

13 Listeners

6 Listeners